"The future vision of the Center for AI-based New Drug Development Facilitation is the development of a global first in class drug that combines artificial intelligence and medical data."

For Hwa Jong Kim (62 years old, director), the direction of organizational management of the Center for AI-based New Drug Development Facilitation is to present a new technological innovation paradigm and create a success model in the pharmaceutical bio industry, the country's new future.

New drug development is an area of cutting-edge convergence technology that requires harmonious fusion of biology, chemistry, medicine, pharmacy, computer science, and business administration.

The direct